CVS Health's Third-Quarter Headwinds Include Hurricane Winds
CVS Health (NYSE: CVS) executives have readily acknowledged that 2017 is a rebuilding year. The pharmacy giant met expectations in the first two quarters of the year, but those expectations were relatively low after CVS lost two major contracts in the second half of last year. So far this year, CVS Health's pharmacy benefits management (PBM) business has been the main source of good news for the company.
The story remained much the same when CVS Health reported its third-quarter results prior to the market open on Monday. This time around, though, CVS Health had some encouraging news for investors. Here are the highlights from the company's third-quarter update.
Image source: Getty Images.
Source: Fool.com
CVS Health Corp. Aktie
56,19 €
3,77 %
Klare Kaufstimmung: CVS Health Corp. hat 27 Buy-Einschätzungen und keine Sell-Einschätzung.
Ein Kursziel von 79 € für CVS Health Corp. würde eine Steigerung von mehr als 20% gegenüber dem aktuellen Kurs von 56.19 € bedeuten.
